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OBJECTIVE—Fasting plasma glucose and risk of type 2 diabe-
tes are higher among Indian Asians than among European and
North American Caucasians. Few studies have investigated ge-
netic factors inﬂuencing glucose metabolism among Indian
Asians.
RESEARCH DESIGN AND METHODS—We carried out ge-
nome-wide association studies for fasting glucose in 5,089 non-
diabetic Indian Asians genotyped with the Illumina Hap610
BeadChip and 2,385 Indian Asians (698 with type 2 diabetes)
genotyped with the Illumina 300 BeadChip. Results were com-
pared with ﬁndings in 4,462 European Caucasians.
RESULTS—We identiﬁed three single nucleotide polymor-
phisms (SNPs) associated with glucose among Indian Asians at
P  5  10
8, all near melatonin receptor MTNR1B. The most
closely associated was rs2166706 (combined P  2.1  10
9),
which is in moderate linkage disequilibrium with rs1387153 (r
2 
0.60) and rs10830963 (r
2  0.45), both previously associated with
glucose in European Caucasians. Risk allele frequency and effect
sizes for rs2166706 were similar among Indian Asians and
European Caucasians: frequency 46.2 versus 45.0%, respectively
(P  0.44); effect 0.05 (95% CI 0.01–0.08) versus 0.05 (0.03–0.07
mmol/l), respectively, higher glucose per allele copy (P  0.84).
SNP rs2166706 was associated with type 2 diabetes in Indian
Asians (odds ratio 1.21 [95% CI 1.06–1.38] per copy of risk allele;
P  0.006). SNPs at the GCK, GCKR, and G6PC2 loci were also
associated with glucose among Indian Asians. Risk allele fre-
quencies of rs1260326 (GCKR) and rs560887 (G6PC2) were
higher among Indian Asians compared with European
Caucasians.
CONCLUSIONS—Common genetic variation near MTNR1B in-
ﬂuences blood glucose and risk of type 2 diabetes in Indian
Asians. Genetic variation at the MTNR1B, GCK, GCKR, and
G6PC2 loci may contribute to abnormal glucose metabolism and
related metabolic disturbances among Indian Asians. Diabetes
58:2703–2708, 2009
T
he World Health Organization estimates that by
2025 there will be 57 million Indian Asians with
type 2 diabetes, (1) by which time one-quarter of
type 2 diabetic patients globally will be Indian
Asian. Migration data among Indian Asians show that the
prevalence of type 2 diabetes is 20% among Indian
Asians in the U.K. and North America compared with
15% in urban Indian and 6% in rural India (2–5).
Although these studies emphasize the importance of envi-
ronmental triggers such as sedentary lifestyle and excess
consumption of energy-dense foods, genetic factors are
also likely to be important (6). Understanding the genetic
mechanisms inﬂuencing glucose metabolism among In-
dian Asians may provide insight into the increased risk of
type 2 diabetes among Indian Asians. Genome-wide asso-
ciation studies have recently identiﬁed common genetic
variation in and around the genes GCK, GCKR, G6PC2,
and MTNR1B as determinants of glucose levels in Euro-
pean populations (7–11). We have carried out a genome-
wide association study of fasting plasma glucose levels in
a population-based cohort of Indian Asian men and
women.
RESEARCH DESIGN AND METHODS
Genome-wide association for fasting plasma glucose was performed among
5,089 nondiabetic Indian Asians (fasting glucose levels 7.0 mmol/l; free from
pharmacologic or dietary treatment for diabetes) (12) and genotyped using the
Illumina Hap610 BeadChip, and a separate sample of 2,385 Indian Asians was
genotyped with the Illumina Hap300 BeadChip. Results for the Hap610 sample
were analyzed separately, followed by meta-analysis of the results from
Hap610 and Hap300 genotyping arrays. To examine the possible contribution
of single nucleotide polymorphisms (SNPs) identiﬁed to raised glucose in
Indian Asians, allele frequencies and effect sizes were compared with results
for 4,462 European Caucasian participants of the Northern Finland Birth
Cohort of 1966 (NFBC1966).
All Indian Asian participants were recruited though the London Life
Sciences Prospective Population (LOLIPOP) Study. LOLIPOP is an ongoing
population-based cohort study of 30,000 Indian Asian and European Cauca-
sian men and women aged 35–75 years and recruited from the patient records
among 58 general practitioners in West London, U.K. (13). Indian Asians were
identiﬁed as having all four grandparents born on the Indian subcontinent.
Response rates averaged 62%; there were no material differences between
responders and nonresponders with respect to age, sex, comorbidity, and
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An interviewer-administered questionnaire was used to collect data on
medical history, family history, current prescribed medication, and cardiovas-
cular risk factors. Physical assessment included anthropometric measure-
ments (height, weight, waist circumference, and hip circumference) and blood
pressure. Blood was collected after an 8-h fast for biochemical analysis,
including glucose, insulin, total and HDL cholesterol, and triglycerides, and
whole blood was taken for extraction of DNA. Insulin sensitivity and
pancreatic -cell function were estimated using the homeostatic model
assessment (HOMA) method (14) where insulin sensitivity (HOMA-S)  22.5
(fasting plasma insulin  fasting plasma glucose) and -cell function (HOMA-
B)  (20  fasting plasma insulin)/(fasting plasma glucose  3.5).
We studied 5,089 nondiabetic Indian Asians genotyped with the Illumina
Hap610 BeadChip (Hap610 sample) and 2,385 Indian Asians genotyped with
the Hap300 BeadChip (Hap300 sample). The Hap300 sample included 698
Indian Asians with type 2 diabetes, enabling testing of SNPs against type 2
diabetic case subject or control subject status.
All European Caucasians were participants of NFBC1966, a study of factors
affecting preterm birth, low birth weight, and subsequent morbidity and
mortality. Participants comprise 12,068 mothers and their 12,231 births in the
provinces of Oulu and Lapland during 1966. At age 31 years, all individuals still
living in the Helsinki area or northern Finland were asked to participate in a
detailed biological and medical examination (n  6,007) including measure-
ment of fasting glucose. For the current study, genotype and fasting glucose
measurements were available for 4,462 NFBC1966 participants (2,116
male and 2,346 female). Study methods and characteristics of participants
have been described previously (11). The University of Oulu ethics
committee approved the study. The NFBC1966 samples used were also
included in the genome-wide association studies that identiﬁed common
genetic variation in and around G6PC2 and MTNR1B as determinants of
glucose levels in European populations (7,9).
Genotyping. Genotyping using the Illumina Hap610 BeadChip was carried
out according to standard methodology. In brief, each sample was whole
genome ampliﬁed, fragmented, precipitated, and resuspended in appropriate
hybridization buffer. Denatured samples were hybridized on prepared Human-
Hap610 BeadChips for a minimum of 16 h at 48°C. After hybridization, the
BeadChips were processed for the single-base extension reaction as well as
staining and imaging on an Illumina Bead Array Reader. Normalized bead
intensity data obtained for each sample were loaded into the Illumina
Beadstudio 2.0 software, which converted ﬂuorescence intensities into SNP
genotypes. Based on 17 duplicate scans, mean genotyping concordance rate
was 99.9987% (range 99.9930–99.9998%). For the 582,539 autosomal SNPs
included on the Hap610 BeadChip, average SNP call rate was 99.7%, with call
rates 95% for 99.7% of SNPs. Call rate was 95% for 99.1% of people; 46
people were excluded for call rates 95%. We also excluded SNPs with minor
allele frequency 0.01, call rate 0.95%, or Hardy-Weinberg equilibrium of
P  10
6. This left 544,390 autosomal SNPs for the genome-wide association
analysis. Methods and quality control for genotyping carried out using the
Illumina Hap300 BeadChip in Indian Asians and the Illumina Hap370 Bead-
Chip in European Caucasians have been described previously (11,13).
Statistics. Single SNP marker tests were carried out for association with
fasting glucose levels in nondiabetic Indian Asians under an additive genetic
model with adjustment for age and sex. Principal components analysis was
used to characterize population substructure in Indian Asians genotyped on
the Hap610 and Hap300 BeadChips, and the top four components were
included in models (15). Analysis of QQ plots for association over all SNPs
showed good adherence to null expectations, indicating that the approach
was sufﬁcient to allow for any inﬂation due to population substructure (see
supplemental Fig. S1, available in the online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db08-1805/DC1).  values for the ge-
nome-wide analyses were 1.01 in both the Illumina Hap610 and the Illumina
Hap300 samples (compared with 1.07 and 1.02, respectively, for analyses
without principal components). The Hap610 sample size provided 80% power
to identify SNPs associated with 0.8% of population variation in glucose at
genome-wide signiﬁcance (P  5  10
8 [16]).
We then carried out a meta-analysis of results from the Illumina Hap610
and the Illumina Hap300 samples. Imputation was done using a hidden Markov
model algorithm implemented in MACH software and pooled phased haplo-
types for the CEU, CHB/JPT, and YRI samples from HapMap build35, dbSNP
build 125 (17). Imputed SNPs with minor allele frequency 0.01 or low-quality
score (r
2  0.30) were removed. This generated 1.9 million directly
genotyped or imputed autosomal SNPs per participant with data available in
both samples. Meta-analysis was carried out using z scores weighted by
square root of sample size, implemented in the software package METAL
(www.sph.umich.edu/csg/abecasis/metal). QQ plots showed good adherence
to null expectations ( for meta-analyzed data  1.047; supplemental Fig. S1).
The associations of SNPs with type 2 diabetes and other phenotypic traits,
and of risk allele score with glucose levels, were tested in the Illumina Hap300
data using regression analysis and an additive genetic model. Analyses were
adjusted for age and sex in Indian Asians as well as for sex among European
Caucasians (NFBC1966 participants are all 31 years of age). Heterogeneity of
effect between Indian Asians and European Caucasians was tested by joint
analysis of data for Indian Asians and European Caucasians, with incorpora-
tion of ethnicity and genotype-ethnicity interaction terms into the regression
models. Two SNP regression models were used to identify whether SNPs from
the same genetic locus have separate relationships with glucose levels.
Glucose risk allele scores were also compared between Indian Asians and
European Caucasians by independent samples t test.
RESULTS
The characteristics of Indian Asian and European Cauca-
sian participants are summarized in Table 1.
Genome-wide association in the Hap610 sample. We
identiﬁed three SNPs associated with glucose levels in
Indian Asians at a genome-wide level of signiﬁcance (P 
5  10
8 [16]) in the Hap610 sample (Table 2; supplemen-
TABLE 1
Characteristics of Indian Asians and European Caucasians studied
Indian Asians
Hap610 sample
Indian Asian Hap300 sample European
Caucasians Nondiabetic Diabetic
n 5,089 1,687 698 4,462
Age (years) 53.9 	 10.6 48.4 	 10.6 56.0 	 10.1 31
Sex (% male) 85 100 100 47.6
Waist-to-hip ratio 0.95 	 0.07 0.96 	 0.07 0.99 	 0.07 0.86 	 0.09
BMI (kg/m
2) 26.8 	 4.2 26.7 	 4.2 27.6 	 4.4 24.6 	 4.2
Known hypertension 35 21 55 19.8
Systolic blood pressure (mmHg) 133.4 	 18.9 132.4 	 20.3 139.9 	 20.5 124.7 	 13.5
Diastolic blood pressure (mmHg) 82.3 	 10.7 82.5 	 12.1 82.9 	 11.8 77.2 	 11.4
Type 2 diabetes 0 0 100 0
Glucose (mmol/l) 5.2 	 0.62 5.1 	 0.6 8.8 	 2.9 5.0 	 0.5
Insulin (IU/l) 11.7 	 8.8 12.1 	 8.6 15.4 	 13.7 8.5 	 4.3
HOMA-B 142 	 124 157 	 122 68 	 224 100 	 29
HOMA-S 0.57 	 1.48 0.55 	 1.33 0.45 	 1.56 1.05 	 0.37
Total cholesterol (mmol/l) 5.21 	 1.12 5.41 	 1.05 4.73 	 1.07 5.09 	 1.01
HDL cholesterol (mmol/l) 1.22 	 0.30 1.24 	 0.31 1.14 	 0.27 1.57 	 0.38
Triglycerides (mmol/l) 1.77 	 1.11 1.64 	 0.81 1.78 	 0.86 1.19 	 0.74
Data are means 	 SD for continuous and percent for categorical traits.
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MTNR1B and in high linkage disequilibrium (LD) with
each other (pairwise r
2  0.5; Fig. 1, supplemental Table
S1). The most closely associated SNP was rs2166706;
when conditioned on rs2166706, there was no evidence for
a separate effect of rs3847554 or rs1387153 on glucose
levels. The associations of rs2166706, rs3847554, and
rs1387153 with glucose levels were conﬁrmed among
Indian Asians in the Hap300 sample, in whom risk allele of
rs2166706 was associated with 0.05 mmol/l higher glu-
cose levels than that for the alternate allele (Table 2).
Further testing of rs2166706 in the Hap300 sample.
The risk allele of SNP rs2166706 was associated with
elevated A1C and reduced HOMA-B among nondiabetic
Indian Asians (Table 3) in the Hap300 sample. In contrast,
there was no association of rs2166706 with weight, BMI,
insulin levels, or HOMA-S (Table 3). Risk allele frequency
of rs2166706 was higher among Indian Asians with type 2
diabetes than among nondiabetic Indian Asians in the
Hap300 sample. The age- and sex-adjusted odds ratio (OR)
for type 2 diabetes was 1.21 (95% CI 1.06–1.38) per copy of
risk allele of rs2166706 among Indian Asians (P  0.006).
After additional adjustment for HOMA-B, OR for type 2
diabetes was reduced and no longer statistically signiﬁcant
(1.12 [0.97–1.30]; P  0.14).
Meta-analysis of genome-wide association data in
Indian Asians. In meta-analysis of the Indian Asian
Hap610 and Hap300 samples, 29 SNPs reached P  5 
10
8. These were distributed in the MTNR1B, GCK, and
G6PC2 loci (supplemental Table S2 and Fig. S2). The LD
structure of the GCK and G6PC2 loci were similar among
Indian Asians and European Caucasians (supplemental
Figs. S3 and S4). Genetic variants near GCKR that have
been associated with glucose levels in European popula-
tions (9,10) were also associated with fasting glucose
levels among Indian Asians, although not at a genome-
wide signiﬁcance level (GCKR: rs1260326, P  3.3  10
4).
Comparisons with European Caucasians. SNP rs2166706
was associated with glucose levels in European Cauca-
sians (Table 2). Based on data from the present study and
on the HapMap CEU population (HapMap PhaseIII/Rel#1
Sept 2008, NCBI B36 assembly, dbSNP b126), SNP
rs2166706 is in moderate LD with both rs1387153 and
rs10830963 (supplemental Table S1), SNPs that have been
reported to be associated with glucose in European Cau-
casians (7,8). Frequencies for risk allele of rs2166706 were
similar among Indian Asians and European Caucasians
(46.2 vs. 45.0%, respectively; P  0.44) with no evidence
for heterogeneity of effect on glucose (P  0.84; Table 2).
Results for association of rs2166706 with secondary phe-
notypes were similar in Indian Asians and European
Caucasians (Table 3) except for HOMA-B, where the
relationship with rs2166706 was weaker and less statisti-
cally signiﬁcant among European Caucasians.
Combined effects of genetic loci inﬂuencing glucose
levels. Risk allele frequencies of rs1260326 (GCKR) and
rs560887 (G6PC2) were higher, and of rs2166706
(MTNR1B) and rs4607517 (GCK) similar, among Indian
Asians and European Caucasians (Table 2 and supplemen-
tal Table S3). Effect sizes on glucose levels at the
MTNR1B, GCKR, G6PC2, and GCK loci were similar
among Indian Asians and European Caucasians, with no
evidence for heterogeneity between the populations (Ta-
ble 2 and supplemental Table S3).
A score comprising number of risk alleles at these four
loci was closely related to glucose levels in both Indian
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unit of allele score: Indian Asians 0.06 	 0.01 mmol/l, P 
1.1  10
16; European Caucasians 0.04 	 0.01 mmol/l, P 
4.6  10
15; Fig. 2). Risk allele score was greater among
Indian Asians than European Caucasians (4.3 	 1.2 vs.
3.8 	 1.3, respectively; P  2.3  10
85; Fig. 2) and
accounted for 1.2% of population variance in glucose
levels in both populations. However, at each level of risk
allele score, Indian Asians had higher glucose levels than
European Caucasians (P  3.3  10
33; Fig. 2).
DISCUSSION
We have identiﬁed and replicated an association of SNP
rs2166706 near MTNR1B with plasma glucose levels and
show that rs2166706 is also associated with increased risk
of type 2 diabetes among Indian Asians. We also replicate
associations of the GCK, GCKR, and G6PC2 loci with
glucose levels in Indian Asians.
Our ﬁndings extend the results of recent studies in
European Caucasian populations that identify genetic vari-
ation near MTNR1B as an important determinant of glu-
cose levels (7,8). MTNR1B encodes a high-afﬁnity receptor
for melatonin, a circulating hormone released by the
pineal gland (18). Secretion of melatonin is tightly regu-
lated by the hypothalamic suprachiasmatic nucleus, the
anatomic center of the mammalian circadian clock (19,20).
Melatonin release is one of the key mechanisms by which
the circadian clock maintains synchronization and regulates
the biologic activities of peripheral tissues (18). Melatonin
receptors (including MTNR1B) are highly expressed in the
hypothalamus, where they contribute to melatonin-induced
negative feedback and phase timing of circadian activity (21).
MTNR1B is also expressed in human pancreatic islet cells
and may mediate the effects of melatonin on basal and
glucose-induced insulin release (22).
Our ﬁndings of an association between SNP rs2166706
near MTNR1B and raised glucose, reduced pancreatic
-cell function, and increased risk of type 2 diabetes are
consistent with accumulating evidence that circadian
clocks play a key role in the regulation of carbohydrate
and energy metabolism. Clock/Clock null mice develop
hyperglycemia, and in humans sleep loss and depression
are associated with circadian desynchronization and in-
creased risk of type 2 diabetes (23–25). Although further
functional studies will be required to clarify the contribu-
tion of peripheral and central melatonin signaling path-
ways to glucose metabolism and type 2 diabetes, our
observations suggest that MTNR1B signaling may be a
FIG. 1. Genomic context of melatonin receptor MTNR1B region showing pairwise LD between SNPs with minor allele frequency >0.05 directly
genotyped in both Indian Asians (A) and European Caucasians (B) using Haploview’s standard color scheme.
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prove glucose regulation and to prevent or treat type 2
diabetes.
We also conﬁrm association of GCK, GCKR, and G6PC2
loci with glucose levels in Indian Asians. Effect sizes were
similar among Indian Asians and European Caucasians,
and a risk allele score was associated with glucose simi-
larly in the two populations. However, risk allele frequen-
cies were higher among Indian Asians than European
Caucasians. These ﬁndings suggest that genetic variation
at these loci makes an important contribution to raised
glucose levels among Indian Asians.
FIG. 1. Continued.
TABLE 3
Associations of rs2166706 with secondary phenotypes among Indian Asians in the Hap300 sample and European Caucasians
Indian Asians P European Caucasians PP hetero
Type 2 diabetes† 1.21 (1.06–1.38) 0.006 — — —
A1C (%)* 0.12 (0.04–0.19) 0.003 — — —
HOMA-B* 7.1 (11.0 to 3.0) 0.001 1.9 (3.6 to 0.2) 0.03 0.02
HOMA-S* 5.4 (4.5 to 16.2) 0.29 3.5 (0.7 to 7.9) 0.10 0.74
BMI (kg/m
2)* 0.17 (0.40 to 0.06) 0.14 0.36 (0.80 to 0.08) 0.11 0.45
Waist-to-hip ratio* 0.001 (0.005 to 0.003) 0.64 0.005 (0.013 to 0.002) 0.16 0.36
Hypertension† 0.93 (0.82–1.05) 0.22 1.00 (0.95–1.06) 0.72 0.28
Systolic blood pressure (mmHg)* 0.9 (1.9 to 0.12) 0.08 0.2 (1.6 to 1.2) 0.79 0.43
Diastolic blood pressure (mmHg)* 0.6 (1.3 to 0.0) 0.05 0.0 (1.2 to 1.2) 0.99 0.39
Cholesterol (mmol/l)* 0.00 (0.05 to 0.06) 0.88 0.02 (0.09 to 0.13) 0.69 0.75
HDL cholesterol (mmol/l)* 0.2 (1.5 to 1.1) 0.78 1.4 (1.1 to 3.9) 0.28 0.27
Triglycerides (mmol/l)* 5.1 (1.0 to 11.7) 0.10 2.1 (7.0 to 3.1) 0.43 0.08
Effects are *unit change (initial to ﬁnal quantity) or †odds ratio (95% CI) per allele copy, under additive genetic model, adjusted for sex (and
age among Indian Asians).
J.C. CHAMBERS AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 58, NOVEMBER 2009 2707These are the ﬁrst data identifying genetic variants that
inﬂuence glucose metabolism among Indian Asians, a
population at high risk for type 2 diabetes and related
metabolic disorders. The 21% of Indian Asians homozy-
gous for the G allele of rs2166706 of MTNR1B have 0.1
mmol/l higher fasting glucose levels and 45% higher odds
of type 2 diabetes compared with people with AA geno-
type. Our ﬁndings give new insight into the genetic mech-
anisms underlying abnormalities of glucose metabolism
among high-risk Indian Asians and provide the basis for
future studies to investigate the role of circadian rhythms
and melatonin signaling in the etiology of type 2 diabetes.
ACKNOWLEDGMENTS
The LOLIPOP study was supported by the British Heart
Foundation (SP/04/002) and the Wellcome Trust.
NFBC1966 study was supported by the Academy of Fin-
land (104781), the Medical Research Council (G0500539),
University Hospital Oulu, Biocenter, University of Oulu,
Finland, National Heart, Lung and Blood Institute Grant
5R01HL087679-02 through the SNP Typing for Association
with Multiple Phenotypes from Existing Epidemiological
Data (STAMPEED) program (1RL1MH083268-01) and the
Wellcome Trust (Project Grant GR069224). The DNA ex-
tractions, sample quality control subjects, biobank up-
keeping, and aliquotting were performed in the national
Public Health Institute, Biomedicum Helsinki, Finland and
supported ﬁnancially by the Academy of Finland (120315)
and Biocentrum Helsinki. For NFBC1966 the wide geno-
typing was conducted by the Broad Institute of Harvard
and Massachusetts Institute of Technology, Cambridge,
Massachusetts.
No potential conﬂicts of interest relevant to this article
were reported.
We thank Nelson Freimer, Leena Peltonen, and the
research teams involved in LOLIPOP and NFBC1966.
REFERENCES
1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025:
prevalence, numerical estimates, and projections. Diabetes Care 1998;21:
1414–1431
2. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin
resistance with high diabetes prevalence and cardiovascular risk in South
Asians. Lancet 1991;337:382–386
3. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concen-
trations and risk of coronary heart disease in UK Indian Asian and
European men. Lancet 2000;355:523–527
4. Mohan V, Deepa M, Deepa R, et al. Secular trends in the prevalence of
diabetes and impaired glucose tolerance in urban South India–the Chennai
Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006;49:1175–
1178
5. Ramachandran A, Snehalatha C, Baskar AD, et al. Temporal changes in
prevalence of diabetes and impaired glucose tolerance associated with
lifestyle transition occurring in the rural population in India. Diabetologia
2004;47:860–865
6. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin
resistance and type 2 diabetes. Nature 2006;444:840–846
7. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNRIB
inﬂuence fasting glucose levels. Nat Genet 2009;41:77–81
8. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenc ¸a C, et al. A variant near
MTNR1B is associated with increased fasting plasma glucose levels and
type 2 diabetes risk. Nat Genet 2009;41:89–94
9. Bouatia-Naji N, Rocheleau G, Van Lommel L, et al. A polymorphism within
the G6PC2 gene is associated with fasting plasma glucose levels. Science
2008;320:1085–1088
10. Vaxillaire M, Cavalcanti-Proenc ¸a C, Dechaume A, et al. The common P446L
polymorphism in GCKR inversely modulates fasting glucose and triglycer-
ide levels and reduces type 2 diabetes risk in the DESIR prospective
general French population. Diabetes 2008;57:2253–2257
11. Sabatti C, Service SK, Hartikainen AL, et al. Genome-wide association
analysis of metabolic traits in a birth cohort from a founder population.
Nat Genet 2009;41:35–46
12. American Diabetes Association. Diagnosis and classiﬁcation of diabetes
mellitus. Diabetes Care 2006;29(Suppl. 1):S43–S48
13. Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variation near
MC4R is associated with waist circumference and insulin resistance. Nat
Genet 2008;40:716–718
14. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling.
Diabetes Care 2004;27:1487–1495
15. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis
corrects for stratiﬁcation in genome-wide association studies. Nat Genet
2006;38:904–909
16. Pe’er I, Yelensky R, Altshuler D, et al. Estimation of the multiple testing
burden for genomewide association studies of nearly all common variants.
Genet Epidemiol 2008;32:381–385
17. Huang L, Li Y, Singleton AB, et al. Genotype-imputation accuracy across
worldwide human populations. Am J Hum Genet 2009;84:235–250
18. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186–195
19. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and
circadian rhythms. Nature 2005;437:1257–1263
20. Reppert SM, Weaver DR. Coordination of circadian timing in mammals.
Nature 2002;418:935–941
21. Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct actions
of melatonin on the suprachiasmatic circadian clock. Neuron 1997;19:91–
102
22. Ramracheya RD, Muller DS, Squires PE, et al. Function and expression of
melatonin receptors on human pancreatic islets. J Pineal Res 2008;44:273–
279
23. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in
circadian Clock mutant mice. Science 2005;308:1043–1045
24. Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional
association between depressive symptoms and diabetes. JAMA 2008;299:
2751–2759
25. Knutson KL, Van Cauter E. Associations between sleep loss and increased
risk of obesity and diabetes. Ann N Y Acad Sci 2008;1129:287–304
FIG. 2. Distribution of risk allele score (number of risk alleles at the
MTNR1B, GCKR, GCK, and G6PC2 loci) among Indian Asians (blue
squares) and European Caucasians (red circles) as well as the rela-
tionship of risk allele score to glucose levels in the two populations.
MTNR1B IN INDIAN ASIANS AND EUROPEAN CAUCASIANS
2708 DIABETES, VOL. 58, NOVEMBER 2009 diabetes.diabetesjournals.org